Industry Background:
Fluticasone propionate is a medication belongs to a corticosteroid class of drugs. It is used in the treatment of allergic rhinitis, asthma, various skin disorders, nasal polyps, ulcerative colitis, and Crohn's disease. Fluticasone propionate market has high growth prospects owing to the increasing prevalence of chronic obstructive pulmonary disease and asthma. In addition, rising demand from the developing economies expected to drive the market demand.
According to AMA Research, the market for Fluticasone propionate is expected to register a CAGR of 4.6% during the forecast period to 2030. This growth is primarily driven by Increasing Number of Patients with Asthmatic Condition
.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Volume Unit | K Units |
Value Unit | USD (Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Chemicals sector in the
region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Vendors, such as GSK (United Kingdom), Teva Pharmaceutical Industries (Israel), West-Ward Pharmaceuticals (United States), Apotex Corp. (United States), Akorn (United States), Wockhardt (India) and OptiNose US, Inc. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
In September 2023, Glenmark Pharmaceuticals launched a new Fluticasone Propionate nasal spray product in India under the brand name Flonase Sensimist. This product is a generic version of GlaxoSmithKline's Flonase Allergy Relief nasal spray.
In August 2023, Mylan Pharmaceuticals launched a new Fluticasone Propionate and Salmeterol combination inhaler product in the United States under the brand name Advair Diskus. This product is a generic version of GlaxoSmithKline's Advair Diskus inhaler.The key manufacturers are targeting the innovations of the products with better quality, better technical characteristics, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking upon mergers and acquisitions in order to maintain their presence in the market
Regulatory Insights:
“According to the National Center for Biotechnology Information, Fluticasone propionate (FP) is a new topical corticosteroid spray used for the treatment of allergic rhinitis and asthma. FP has been shown to be effective for the treatment of adult and pediatric asthma, even at rather low doses (25 microg twice daily [b.i.d.]); many studies in asthma have shown clinical efficacy of fluticasone at half the dose of the comparison steroid (such as beclomethasone dipropionate [BDP] or budesonide [BUD]). However, exact dose comparisons cannot be made because dose-ranging comparison studies have not been done. Studies in allergic rhinitis in children and adults have shown good efficacy in FP-treated patients at a dose of 200 microg once daily (o.d.), intranasally.”
Influencing Trend:
Increasing Applications in the Treatment of Allergic and Non-Allergic Nasal Indications
Market Growth Drivers:
Increasing Number of Patients with Asthmatic Condition and Growing Demand for Nasal Sprays
Challenges:
Side Effects Such As Sinusitis, Upper Respiratory Tract Infections, and Others
Restraints:
Stringent Government Regulations Regarding Fluticasone Propionate
Opportunities:
Growing Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Increasing Demand from the Developing Economies
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Vendors landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Data Sources of Fluticasone propionate Market Study
Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Fluticasone propionate Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.
The primary interviews and data collected as per the below protocols: By Designation: C-Level, D-Level, Others
By Company Type: Tier 1, Tier 2, Tier 3
Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Fluticasone propionate players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Fluticasone propionate Study Sheds Light on
The Fluticasone propionate Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Fluticasone propionate industry Vendors. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Fluticasone propionate industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Vendors can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.